Optic Nerve Sheath Measurement and Angiogenic Factors for the Diagnosis of Pre-eclampsia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pre-Eclampsia
- Sponsor
- Saint Thomas Hospital, Panama
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Optic nerve sheath diameter cut off value
- Status
- Recruiting
- Last Updated
- 8 months ago
Overview
Brief Summary
Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit. Refining the diagnostic capability of this test would further improve maternal-fetal outcomes and the use of optic nerve sheath diameter (ONSD) measurement could make the difference.
The purpose of the present study is to correlate the measurement of ONSD with serum angiogenic factor (AF) values in patients with pre-eclampsia and to determine its predictive ability for adverse perinatal outcomes.
Investigators
Osvaldo A. Reyes T.
Head of the research deparment
Saint Thomas Hospital, Panama
Eligibility Criteria
Inclusion Criteria
- •Pregnant women between 24 and 40 weeks of gestation.
Exclusion Criteria
- •Multiple gestation
- •Maternal vasculitis
- •Previous cesarean section (3 or more)
- •Brain or eye tumors
- •Neurological conditions
- •Chronic renal disease
- •Heart disease
Outcomes
Primary Outcomes
Optic nerve sheath diameter cut off value
Time Frame: Up to discharge. On average, 7 days.
Value in mms of the optic nerve sheath diameter for the diagnosis of severe preeclampsia
sFLT-1/PiGF index
Time Frame: Up until discharge. On average, 7 days
Value of the index between the sFlt-1/PIGF (angiogenic factor) for the diagnosis of severe preeclampsia
Secondary Outcomes
- Maternal/fetal morbidity(Up until discharge. On average, 7 days)
- Neonatal morbidity(Up until discharge. On average, 3 days)